Core Laboratories Stock Forecast, Price & News

+0.01 (+0.04 %)
(As of 09/21/2021 12:44 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume6,765 shs
Average Volume497,936 shs
Market Capitalization$1.27 billion
P/E Ratio38.17
Dividend Yield0.15%
30 days | 90 days | 365 days | Advanced Chart
Receive CLB News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Core Laboratories logo

About Core Laboratories

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

1.99 out of 5 stars

Oils/Energy Sector

146th out of 346 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

9th out of 28 stocks

Analyst Opinion: 0.9Community Rank: 3.9Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Core Laboratories (NYSE:CLB) Frequently Asked Questions

Is Core Laboratories a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 2 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Core Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View analyst ratings for Core Laboratories
or view top-rated stocks.

What stocks does MarketBeat like better than Core Laboratories?

Wall Street analysts have given Core Laboratories a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Core Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Core Laboratories' next earnings date?

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, October 20th 2021.
View our earnings forecast for Core Laboratories

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its quarterly earnings data on Wednesday, July, 28th. The oil and gas company reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.19 by $0.01. The oil and gas company earned $118.75 million during the quarter, compared to analysts' expectations of $118.85 million. Core Laboratories had a net margin of 7.32% and a trailing twelve-month return on equity of 27.46%.
View Core Laboratories' earnings history

How has Core Laboratories' stock price been impacted by COVID-19?

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CLB shares have increased by 151.0% and is now trading at $27.43.
View which stocks have been most impacted by COVID-19

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Friday, July 30th. Shareholders of record on Monday, August 9th will be given a dividend of $0.01 per share on Tuesday, August 24th. This represents a $0.04 annualized dividend and a yield of 0.15%. The ex-dividend date is Friday, August 6th.
View Core Laboratories' dividend history

Is Core Laboratories a good dividend stock?

Core Laboratories pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.15%. Core Laboratories does not yet have a strong track record of dividend growth. The dividend payout ratio of Core Laboratories is 5.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.36% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its third quarter 2021 earnings guidance on Wednesday, August, 4th. The company provided earnings per share guidance of $0.190-$0.210 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.230. The company issued revenue guidance of $122 million-$126 million, compared to the consensus revenue estimate of $125.67 million.

What price target have analysts set for CLB?

8 Wall Street analysts have issued 1 year price targets for Core Laboratories' stock. Their forecasts range from $17.50 to $37.00. On average, they expect Core Laboratories' share price to reach $26.42 in the next twelve months. This suggests that the stock has a possible downside of 3.7%.
View analysts' price targets for Core Laboratories
or view top-rated stocks among Wall Street analysts.

Who are Core Laboratories' key executives?

Core Laboratories' management team includes the following people:
  • Lawrence V. Bruno, Chairman-Supervisory Board, President, CEO & COO
  • Christopher S. Hill, Chief Financial Officer & Senior Vice President
  • Mark F. Elvig, Secretary, Vice President & General Counsel
  • J. Donald Dumas, Vice President-Business Development
  • Kevin Daniels, Chief Accounting Officer

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Core Laboratories' key competitors?

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.45%), Vanguard Group Inc. (10.68%), Ariel Investments LLC (7.73%), Massachusetts Financial Services Co. MA (5.40%), Van ECK Associates Corp (4.45%) and Clearbridge Investments LLC (3.48%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories

Which major investors are selling Core Laboratories stock?

CLB stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Edgestream Partners L.P., Ariel Investments LLC, BlackRock Inc., Clearbridge Investments LLC, Fisher Asset Management LLC, Mairs & Power Inc., and Bank of New York Mellon Corp.
View insider buying and selling activity for Core Laboratories
or view top insider-selling stocks.

Which major investors are buying Core Laboratories stock?

CLB stock was acquired by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Morgan Stanley, Morgan Stanley, AKO Capital LLP, Confluence Investment Management LLC, Vanguard Group Inc., Invesco Ltd., and Amundi. Company insiders that have bought Core Laboratories stock in the last two years include Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories
or or view top insider-buying stocks.

How do I buy shares of Core Laboratories?

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $27.43.

How much money does Core Laboratories make?

Core Laboratories has a market capitalization of $1.27 billion and generates $487.27 million in revenue each year. The oil and gas company earns $-97,640,000.00 in net income (profit) each year or $0.80 on an earnings per share basis.

How many employees does Core Laboratories have?

Core Laboratories employs 3,700 workers across the globe.

When was Core Laboratories founded?

Core Laboratories was founded in 1936.

What is Core Laboratories' official website?

The official website for Core Laboratories is www.corelab.com.

Where are Core Laboratories' headquarters?

Core Laboratories is headquartered at STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at (120) 420-3191 or via email at [email protected].

This page was last updated on 9/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.